jollibee 6 pcs www jilibet.com jollibee breakfast menu ubet casino login jolibet 3 login
Current location: jilibet slots > jollibee 6 pcs > 777-777

777-777

Release time: 2025-01-10 | Source: Unknown
777-777

Rhode Island beats Bryant 35-21 to claim its first Coastal Athletic Association title

NoneDarren Kennedy: 2024’s Christmas interiors are about warmth, glamour and eco-friendliness — here’s how to get the look in your home

Pregnant Charlotte Crosby ‘rushed to hospital’ days after home robbery attemptInto the earthOneDigital Investment Advisors LLC Acquires Shares of 5,435 Valvoline Inc. (NYSE:VVV)ATLANTA (AP) — Ethan Vasko threw three touchdown passes and ran for a fourth as Coastal Carolina became bowl eligible by beating Georgia State 48-27 for its sixth win of the season in the regular season finale on Saturday. The Chanticleers evened their season record at 6-6 with the win and finished 3-5 in the Sun Belt East. The loss leaves Georgia State (3-9) with just one win in eight conference games. Vasko threw 10 yards to Senika McKie for the game's first score midway through the first quarter, but the Panthers got a Liam Rickman 28-yard field goal and a 19-yard touchdown run by Freddie Brock to take a 10-7 second-quarter lead. Vasko threw his second TD pass, this one a five-yard strike to Zach Courtney to take the lead and Kade Hensley booted a 43-yard field goal as time expired to put Coastal Carolina up 17-10 at halftime. Christian Washington ran 18-yards for a touchdown to open up a 24-10 lead four minutes into the third quarter. Vasko hit McKie for their second touchdown, this one from 31-yards out and Vasko ran 10 yards for a fourth-quarter touchdown to make it 38-10 with under 10 minutes to play. Vasko was 13 of 17 passing for 200 yards and carried 13 times for another 68. Washington carried 20 times for 124 yards. McKie caught five passes for 81 yards Georgia State amassed 428 yards of offense, but the Panthers turned the ball over six times. Christian Veilleux completed 15 of 26 passes for 205 yards but was picked off four times and fumbled. Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-football

Atria Investments Inc cut its stake in Spire Inc. ( NYSE:SR – Free Report ) by 14.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,060 shares of the utilities provider’s stock after selling 698 shares during the period. Atria Investments Inc’s holdings in Spire were worth $273,000 at the end of the most recent quarter. A number of other institutional investors have also recently modified their holdings of the stock. Assenagon Asset Management S.A. lifted its holdings in shares of Spire by 197.4% during the 2nd quarter. Assenagon Asset Management S.A. now owns 162,195 shares of the utilities provider’s stock worth $9,850,000 after acquiring an additional 107,662 shares during the period. AQR Capital Management LLC boosted its holdings in shares of Spire by 290.9% in the 2nd quarter. AQR Capital Management LLC now owns 130,827 shares of the utilities provider’s stock valued at $7,877,000 after purchasing an additional 97,358 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Spire by 8.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 944,387 shares of the utilities provider’s stock valued at $57,351,000 after purchasing an additional 72,119 shares during the last quarter. Victory Capital Management Inc. raised its holdings in shares of Spire by 11.0% during the 2nd quarter. Victory Capital Management Inc. now owns 698,819 shares of the utilities provider’s stock worth $42,439,000 after buying an additional 69,020 shares in the last quarter. Finally, Vanguard Group Inc. lifted its position in shares of Spire by 1.2% during the 1st quarter. Vanguard Group Inc. now owns 5,626,863 shares of the utilities provider’s stock worth $345,321,000 after buying an additional 65,486 shares during the last quarter. 87.36% of the stock is currently owned by institutional investors. Analyst Upgrades and Downgrades A number of research firms have issued reports on SR. StockNews.com cut Spire from a “hold” rating to a “sell” rating in a research report on Thursday. Stifel Nicolaus decreased their price target on shares of Spire from $70.00 to $69.00 and set a “hold” rating on the stock in a report on Friday. Mizuho increased their price objective on shares of Spire from $62.00 to $65.00 and gave the company a “neutral” rating in a research note on Tuesday. Morgan Stanley decreased their target price on shares of Spire from $77.00 to $75.00 and set an “equal weight” rating on the stock in a research note on Friday. Finally, LADENBURG THALM/SH SH downgraded shares of Spire from a “neutral” rating to a “sell” rating and lowered their price target for the stock from $65.50 to $60.50 in a report on Thursday, October 17th. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $68.06. Spire Trading Up 2.7 % SR opened at $72.55 on Friday. The company has a debt-to-equity ratio of 1.11, a current ratio of 0.48 and a quick ratio of 0.35. Spire Inc. has a fifty-two week low of $56.36 and a fifty-two week high of $72.71. The company’s 50 day moving average price is $65.74 and its two-hundred day moving average price is $63.76. The firm has a market capitalization of $4.19 billion, a price-to-earnings ratio of 17.44, a PEG ratio of 3.00 and a beta of 0.52. Spire Increases Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 3rd. Investors of record on Wednesday, December 11th will be paid a $3.14 dividend. This is a boost from Spire’s previous quarterly dividend of $0.76. The ex-dividend date is Wednesday, December 11th. This represents a $12.56 annualized dividend and a dividend yield of 17.31%. Spire’s payout ratio is currently 72.60%. Spire Profile ( Free Report ) Spire Inc, together with its subsidiaries, engages in the purchase, retail distribution, and sale of natural gas to residential, commercial, industrial, and other end-users of natural gas in the United States. The company operates through three segments: Gas Utility, Gas Marketing, and Midstream. It is also involved in the marketing of natural gas and related services; and transportation and storage of natural gas. Recommended Stories Five stocks we like better than Spire How to Use the MarketBeat Excel Dividend Calculator Tesla Investors Continue to Profit From the Trump Trade Differences Between Momentum Investing and Long Term Investing MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index Netflix Ventures Into Live Sports, Driving Stock Momentum Want to see what other hedge funds are holding SR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Spire Inc. ( NYSE:SR – Free Report ). Receive News & Ratings for Spire Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire and related companies with MarketBeat.com's FREE daily email newsletter .Edwards Lifesciences Co. ( NYSE:EW – Get Free Report ) has received a consensus rating of “Hold” from the twenty-six analysts that are currently covering the company, Marketbeat Ratings reports. Sixteen analysts have rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 1 year target price among brokerages that have covered the stock in the last year is $75.67. A number of equities analysts have weighed in on the company. Piper Sandler reduced their price objective on Edwards Lifesciences from $73.00 to $70.00 and set a “neutral” rating for the company in a research note on Friday, October 25th. Barclays reduced their price objective on Edwards Lifesciences from $90.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, September 9th. Citigroup reduced their price objective on Edwards Lifesciences from $83.00 to $77.00 and set a “buy” rating for the company in a research note on Tuesday, October 1st. JPMorgan Chase & Co. lifted their price objective on Edwards Lifesciences from $72.00 to $78.00 and gave the company a “neutral” rating in a research note on Friday, October 25th. Finally, Sanford C. Bernstein upgraded Edwards Lifesciences from a “strong sell” rating to a “hold” rating in a research note on Monday, October 28th. Get Our Latest Report on EW Insider Transactions at Edwards Lifesciences Institutional Trading of Edwards Lifesciences A number of large investors have recently modified their holdings of the stock. Crewe Advisors LLC acquired a new position in Edwards Lifesciences in the first quarter valued at $28,000. First Community Trust NA acquired a new position in Edwards Lifesciences in the second quarter valued at $29,000. FSA Wealth Management LLC acquired a new position in Edwards Lifesciences in the third quarter valued at $30,000. Prospera Private Wealth LLC acquired a new position in Edwards Lifesciences in the third quarter valued at $32,000. Finally, Avior Wealth Management LLC boosted its stake in Edwards Lifesciences by 138.7% in the third quarter. Avior Wealth Management LLC now owns 530 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 308 shares in the last quarter. Hedge funds and other institutional investors own 79.46% of the company’s stock. Edwards Lifesciences Stock Up 0.2 % Shares of NYSE EW opened at $70.49 on Wednesday. The company has a current ratio of 3.46, a quick ratio of 2.89 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $41.58 billion, a PE ratio of 10.17, a price-to-earnings-growth ratio of 3.95 and a beta of 1.12. The stock’s fifty day simple moving average is $67.70 and its two-hundred day simple moving average is $75.73. Edwards Lifesciences has a 12-month low of $58.93 and a 12-month high of $96.12. Edwards Lifesciences ( NYSE:EW – Get Free Report ) last posted its quarterly earnings data on Thursday, October 24th. The medical research company reported $0.67 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.67. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.57 billion. Edwards Lifesciences had a return on equity of 20.76% and a net margin of 70.82%. The business’s quarterly revenue was up 8.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.59 EPS. As a group, analysts expect that Edwards Lifesciences will post 2.57 EPS for the current fiscal year. Edwards Lifesciences Company Profile ( Get Free Report Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. Recommended Stories Receive News & Ratings for Edwards Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edwards Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter .

Two CMFRI scientists win NAAS recognition

UK’s ‘most depressing town’ was voted by tourists but fuming locals insist popular seaside spot is ‘gorgeous’‘Buy now, pay later’ is more popular than ever. It can cost more than you think

Former Pakistan Prime Minister Imran Khan’s wife Bushra Bibi has come under a severe attack by the ruling government and other political parties over her recent controversial statement about Saudi Arabia, forcing the jailed leader and his political party Pakistan Tehreek-e-Insaf (PTI) to rush to her rescue and go in a full damage-control mode. Bushra Bibi released a video recently, urging everyone to take to the streets on Sunday (November 24) to protest against the “illegal imprisonment” of her husband Imran Khan. In the video, she also stated that Saudi Arabia was offended when they saw Imran Khan arriving barefoot to visit Madina. This, she claimed, resulted in multiple calls to then Army Chief (Retd.) General Qamar Jawed Bajwa, expressed concerns over Khan showing himself as the representative of Islam and Shariah to them at a time when they (Saudis) are abolishing it from their own country. The statement prompted immediate response from Pakistan Prime Minister Shehbaz Sharif, who slammed Imran Khan and his wife Bushra Bibi, warning that any attempts to dent relations between Pakistan and Saudi Arabia would not be tolerated at all. On the other hand, PTI leadership maintained that, as Bushra is not a political figure, her statement should not be attributed to the party at large. “Bushra Bibi’s statement has nothing to do with PTI,” said senior PTI leader Shoaib Shaheen. However, Imran Khan seems to be endorsing what his wife had said. While speaking to the media from Rawalpindi’s Adiala Jail, Khan said that his wife had not named Saudi Arabia and that the statement was being twisted to directly target MBS (Muhammad Bin Salman) and Saudi Arabia. Imran Khan’s endorsement of his wife’s controversial statement was also picked up by the government, which slammed both of them for towing anti-state and anti-Pakistan agenda. “Imran Khan did not negate what his wife said and, in fact, he endorsed it. Imran Khan, his party and his so-called non-political wife are on an anti-Pakistan agenda. They are enemies of Pakistan. They can go to any extent to damage our country and its relationship with brotherly countries like Saudi Arabia,” said Azma Bukhari, spokesperson of the Punjab government. “This disgraceful statement from an uneducated and uninformed individual against friendly countries shows she is working on the agenda of hostile elements. The people of Pakistan have now witnessed the true faces of these two deceivers. The so-called ‘Fitna Party’ is no longer acceptable to the nation,” she added while speaking with reporters in Lahore on Saturday.

Election victories for Donald Trump and other candidates whose campaigns demeaned transgender people reinforced a widespread backlash against trans rights. For America’s LGBTQ-rights movement, it adds up to one of the most sustained setbacks in its history. For transgender Americans, it’s personal: There is palpable fear of potential Trump administration steps to further marginalize them. But there is also a spirit of resilience — a determination to persevere in seeking acceptance and understanding. “I just went through an election where I couldn’t watch a sports event on TV without seeing a commercial where trans people were portrayed as monsters,” said Jennifer Finney Boylan, a transgender author who teaches at Barnard College in New York. “This hurts more than any other moment I can remember. We’ve been knocked down before. We’ll be knocked down again. All we can do is fight.” Anti-trans momentum has been growing for several years, with Republican-governed states enacting dozens of laws restricting trans people’s options for medical care, sports participation and public restroom access. Activists fear the movement will grow, with the Trump administration taking power as many Americans question the trans-rights agenda. Overall, 55% of voters — and 85% of Trump backers — said support for transgender rights in government and society has gone too far, according to AP VoteCast, a survey of more than 120,000 people who cast ballots nationwide. “There is an urgent need to show the American people the reality of transgender lives — the ordinary people for whom being trans is not the center of their lives,” said Shannon Minter, a transgender civil rights lawyer with the National Center for Lesbian Rights. “This is a frightening moment for transgender people and their families. There is a very real possibility that the new administration may adopt policies that cause them devastating harm.” Trump won the presidential contest over Vice President Kamala Harris after a campaign that included pervasive TV advertising mocking her support for trans rights. “Kamala is for they/them,” an ad that ran over 15,000 times asserted. “President Trump is for you.” Other Democratic candidates also were targeted with anti-trans ads. On an array of issues, Trump — and other Republicans who now hold majorities in both the House and Senate — have threatened to roll back protections and civil liberties for trans people. Education: Trump has pledged to impose wide-ranging restrictions on transgender students. His administration could swiftly move to exclude them from Title IX protections, which affect school policies on students’ use of preferred pronouns, bathrooms and locker rooms. Health care: At least 26 states have adopted laws restricting or banning gender-affirming medical care for trans minors. In Texas, Attorney General Ken Paxton is filing civil lawsuits against doctors he alleges were prescribing such treatments. Trump says any doctor or hospital providing gender-affirming care should be barred from Medicaid and Medicare. Sports: Trump and other Republicans embraced the anti-trans mantra opposing “boys in girls’ sports.” At least 24 states already have laws on the books barring trans women and girls from participating in certain women’s or girls’ sports competitions. In March, 16 college athletes filed a lawsuit against the NCAA, accusing it of violating their Title IX rights by allowing transgender woman Lia Thomas to compete at the 2022 national championships, where she won the 500-yard freestyle. Military: Trans-rights activists worry that Trump may reimpose a ban on trans people serving openly in the military or — as an alternative — bar any future recruiting of trans people and curtail the availability of gender-affirming medical care for service members and veterans. Trans-rights organizations are calling for coalition-building and renewed efforts to increase public understanding. They celebrated some notable victories. Sarah McBride won Delaware’s lone seat in the House of Representatives to become the first openly trans person elected to Congress. In Montana, transgender state Rep. Zooey Zephyr won reelection and will be able to return to the House floor nearly two years after she was silenced and sanctioned by her Republican colleagues. But nationwide, anger and anxiety were dominant emotions among trans activists. “This election season has been brutal,” the leaders of Advocates for Transgender Equality wrote to their supporters. “Trump targeted trans people since his campaign launch. He targeted our existence. He targeted our rights. He promised he would continue to target trans people if he won — and we know he will keep his promise.” Shelby Chestnut, executive director of the Transgender Law Center, said trans people “have become the pawn for political groups that don’t understand our communities.” “It’s a very precarious time,” Chestnut said. “We will get through this, but we have to step up and support each other. ... How do we see the long game, not just the immediate narrow view? Because it is very daunting right now. Where do we want to be in 15 years?” Public opinion on trans rights issues isn’t uniform. According to AP VoteCast, slightly more than half of voters in the 2024 election strongly or somewhat opposed laws that ban gender-affirming medical treatment, such as puberty blockers and hormone therapy, for minors. Slightly less than half of voters somewhat or strongly favored them. And according to a Gallup poll conducted last year, 69% of Americans say transgender athletes should be allowed to compete only on sports teams that conform with their birth gender. Over the past 25 years, arguably the most daunting previous phase of the LGBTQ-rights movement started in 2004, after Massachusetts became the first state to legalize same-sex marriage. Between 2004 and 2008, voters in 26 states approved ballot measures defining marriage as between one man and one woman — in effect outlawing same-sex marriage. By 2012, however, public opinion was swinging in favor of same-sex marriage. The Supreme Court legalized it nationwide in 2015, and it has had the support of most Americans ever since. Boylan recalled how that long-bitter debate tilted in favor of legalization when supporters of same-sex marriage popularized the phrase “Love is love.” “That opened doors and opened hearts,” Boylan said. “The challenge for trans people is we don’t have a phrase like that. ... The issues are more complex.” Boylan noted that the anti-trans campaign seemed to make headway with issues that are not among the core concerns of most trans people: “The primary thing we’re fighting for is not the right to play with other women on a soccer team. We’re fighting for dignity, for respect, for the right to be left alone.” Maxwell Kuzma, a transgender man working as a film editor and writer in rural Ohio, said he was “worn out” by the relentless targeting of trans people and blamed Trump for perpetuating it. Looking ahead, he said life as a trans person “has forced me to learn a resiliency that I will lean on as I continue to speak out against prejudice and discrimination.” Christine Zuba, a transgender woman from New Jersey, described a recent surge of Zoom meetings enabling trans people to express their concerns and determine next steps. “One of the best recommendations I have heard throughout this discussion is to not isolate yourself; rather surround yourself with your support group — the people you love and who love you,” she said. “Do not despair. There are a lot of people who will work with you and for you.” Get local news delivered to your inbox!

Jayden Daniels and the offense stalling have the Commanders on a three-game losing streak

Taylor Swift sends fans in frenzy with highly anticipated Easter EggNone

777-777

Rhode Island beats Bryant 35-21 to claim its first Coastal Athletic Association title

NoneDarren Kennedy: 2024’s Christmas interiors are about warmth, glamour and eco-friendliness — here’s how to get the look in your home

Pregnant Charlotte Crosby ‘rushed to hospital’ days after home robbery attemptInto the earthOneDigital Investment Advisors LLC Acquires Shares of 5,435 Valvoline Inc. (NYSE:VVV)ATLANTA (AP) — Ethan Vasko threw three touchdown passes and ran for a fourth as Coastal Carolina became bowl eligible by beating Georgia State 48-27 for its sixth win of the season in the regular season finale on Saturday. The Chanticleers evened their season record at 6-6 with the win and finished 3-5 in the Sun Belt East. The loss leaves Georgia State (3-9) with just one win in eight conference games. Vasko threw 10 yards to Senika McKie for the game's first score midway through the first quarter, but the Panthers got a Liam Rickman 28-yard field goal and a 19-yard touchdown run by Freddie Brock to take a 10-7 second-quarter lead. Vasko threw his second TD pass, this one a five-yard strike to Zach Courtney to take the lead and Kade Hensley booted a 43-yard field goal as time expired to put Coastal Carolina up 17-10 at halftime. Christian Washington ran 18-yards for a touchdown to open up a 24-10 lead four minutes into the third quarter. Vasko hit McKie for their second touchdown, this one from 31-yards out and Vasko ran 10 yards for a fourth-quarter touchdown to make it 38-10 with under 10 minutes to play. Vasko was 13 of 17 passing for 200 yards and carried 13 times for another 68. Washington carried 20 times for 124 yards. McKie caught five passes for 81 yards Georgia State amassed 428 yards of offense, but the Panthers turned the ball over six times. Christian Veilleux completed 15 of 26 passes for 205 yards but was picked off four times and fumbled. Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-football

Atria Investments Inc cut its stake in Spire Inc. ( NYSE:SR – Free Report ) by 14.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,060 shares of the utilities provider’s stock after selling 698 shares during the period. Atria Investments Inc’s holdings in Spire were worth $273,000 at the end of the most recent quarter. A number of other institutional investors have also recently modified their holdings of the stock. Assenagon Asset Management S.A. lifted its holdings in shares of Spire by 197.4% during the 2nd quarter. Assenagon Asset Management S.A. now owns 162,195 shares of the utilities provider’s stock worth $9,850,000 after acquiring an additional 107,662 shares during the period. AQR Capital Management LLC boosted its holdings in shares of Spire by 290.9% in the 2nd quarter. AQR Capital Management LLC now owns 130,827 shares of the utilities provider’s stock valued at $7,877,000 after purchasing an additional 97,358 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Spire by 8.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 944,387 shares of the utilities provider’s stock valued at $57,351,000 after purchasing an additional 72,119 shares during the last quarter. Victory Capital Management Inc. raised its holdings in shares of Spire by 11.0% during the 2nd quarter. Victory Capital Management Inc. now owns 698,819 shares of the utilities provider’s stock worth $42,439,000 after buying an additional 69,020 shares in the last quarter. Finally, Vanguard Group Inc. lifted its position in shares of Spire by 1.2% during the 1st quarter. Vanguard Group Inc. now owns 5,626,863 shares of the utilities provider’s stock worth $345,321,000 after buying an additional 65,486 shares during the last quarter. 87.36% of the stock is currently owned by institutional investors. Analyst Upgrades and Downgrades A number of research firms have issued reports on SR. StockNews.com cut Spire from a “hold” rating to a “sell” rating in a research report on Thursday. Stifel Nicolaus decreased their price target on shares of Spire from $70.00 to $69.00 and set a “hold” rating on the stock in a report on Friday. Mizuho increased their price objective on shares of Spire from $62.00 to $65.00 and gave the company a “neutral” rating in a research note on Tuesday. Morgan Stanley decreased their target price on shares of Spire from $77.00 to $75.00 and set an “equal weight” rating on the stock in a research note on Friday. Finally, LADENBURG THALM/SH SH downgraded shares of Spire from a “neutral” rating to a “sell” rating and lowered their price target for the stock from $65.50 to $60.50 in a report on Thursday, October 17th. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $68.06. Spire Trading Up 2.7 % SR opened at $72.55 on Friday. The company has a debt-to-equity ratio of 1.11, a current ratio of 0.48 and a quick ratio of 0.35. Spire Inc. has a fifty-two week low of $56.36 and a fifty-two week high of $72.71. The company’s 50 day moving average price is $65.74 and its two-hundred day moving average price is $63.76. The firm has a market capitalization of $4.19 billion, a price-to-earnings ratio of 17.44, a PEG ratio of 3.00 and a beta of 0.52. Spire Increases Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 3rd. Investors of record on Wednesday, December 11th will be paid a $3.14 dividend. This is a boost from Spire’s previous quarterly dividend of $0.76. The ex-dividend date is Wednesday, December 11th. This represents a $12.56 annualized dividend and a dividend yield of 17.31%. Spire’s payout ratio is currently 72.60%. Spire Profile ( Free Report ) Spire Inc, together with its subsidiaries, engages in the purchase, retail distribution, and sale of natural gas to residential, commercial, industrial, and other end-users of natural gas in the United States. The company operates through three segments: Gas Utility, Gas Marketing, and Midstream. It is also involved in the marketing of natural gas and related services; and transportation and storage of natural gas. Recommended Stories Five stocks we like better than Spire How to Use the MarketBeat Excel Dividend Calculator Tesla Investors Continue to Profit From the Trump Trade Differences Between Momentum Investing and Long Term Investing MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index Netflix Ventures Into Live Sports, Driving Stock Momentum Want to see what other hedge funds are holding SR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Spire Inc. ( NYSE:SR – Free Report ). Receive News & Ratings for Spire Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire and related companies with MarketBeat.com's FREE daily email newsletter .Edwards Lifesciences Co. ( NYSE:EW – Get Free Report ) has received a consensus rating of “Hold” from the twenty-six analysts that are currently covering the company, Marketbeat Ratings reports. Sixteen analysts have rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 1 year target price among brokerages that have covered the stock in the last year is $75.67. A number of equities analysts have weighed in on the company. Piper Sandler reduced their price objective on Edwards Lifesciences from $73.00 to $70.00 and set a “neutral” rating for the company in a research note on Friday, October 25th. Barclays reduced their price objective on Edwards Lifesciences from $90.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, September 9th. Citigroup reduced their price objective on Edwards Lifesciences from $83.00 to $77.00 and set a “buy” rating for the company in a research note on Tuesday, October 1st. JPMorgan Chase & Co. lifted their price objective on Edwards Lifesciences from $72.00 to $78.00 and gave the company a “neutral” rating in a research note on Friday, October 25th. Finally, Sanford C. Bernstein upgraded Edwards Lifesciences from a “strong sell” rating to a “hold” rating in a research note on Monday, October 28th. Get Our Latest Report on EW Insider Transactions at Edwards Lifesciences Institutional Trading of Edwards Lifesciences A number of large investors have recently modified their holdings of the stock. Crewe Advisors LLC acquired a new position in Edwards Lifesciences in the first quarter valued at $28,000. First Community Trust NA acquired a new position in Edwards Lifesciences in the second quarter valued at $29,000. FSA Wealth Management LLC acquired a new position in Edwards Lifesciences in the third quarter valued at $30,000. Prospera Private Wealth LLC acquired a new position in Edwards Lifesciences in the third quarter valued at $32,000. Finally, Avior Wealth Management LLC boosted its stake in Edwards Lifesciences by 138.7% in the third quarter. Avior Wealth Management LLC now owns 530 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 308 shares in the last quarter. Hedge funds and other institutional investors own 79.46% of the company’s stock. Edwards Lifesciences Stock Up 0.2 % Shares of NYSE EW opened at $70.49 on Wednesday. The company has a current ratio of 3.46, a quick ratio of 2.89 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $41.58 billion, a PE ratio of 10.17, a price-to-earnings-growth ratio of 3.95 and a beta of 1.12. The stock’s fifty day simple moving average is $67.70 and its two-hundred day simple moving average is $75.73. Edwards Lifesciences has a 12-month low of $58.93 and a 12-month high of $96.12. Edwards Lifesciences ( NYSE:EW – Get Free Report ) last posted its quarterly earnings data on Thursday, October 24th. The medical research company reported $0.67 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.67. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.57 billion. Edwards Lifesciences had a return on equity of 20.76% and a net margin of 70.82%. The business’s quarterly revenue was up 8.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.59 EPS. As a group, analysts expect that Edwards Lifesciences will post 2.57 EPS for the current fiscal year. Edwards Lifesciences Company Profile ( Get Free Report Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. Recommended Stories Receive News & Ratings for Edwards Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edwards Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter .

Two CMFRI scientists win NAAS recognition

UK’s ‘most depressing town’ was voted by tourists but fuming locals insist popular seaside spot is ‘gorgeous’‘Buy now, pay later’ is more popular than ever. It can cost more than you think

Former Pakistan Prime Minister Imran Khan’s wife Bushra Bibi has come under a severe attack by the ruling government and other political parties over her recent controversial statement about Saudi Arabia, forcing the jailed leader and his political party Pakistan Tehreek-e-Insaf (PTI) to rush to her rescue and go in a full damage-control mode. Bushra Bibi released a video recently, urging everyone to take to the streets on Sunday (November 24) to protest against the “illegal imprisonment” of her husband Imran Khan. In the video, she also stated that Saudi Arabia was offended when they saw Imran Khan arriving barefoot to visit Madina. This, she claimed, resulted in multiple calls to then Army Chief (Retd.) General Qamar Jawed Bajwa, expressed concerns over Khan showing himself as the representative of Islam and Shariah to them at a time when they (Saudis) are abolishing it from their own country. The statement prompted immediate response from Pakistan Prime Minister Shehbaz Sharif, who slammed Imran Khan and his wife Bushra Bibi, warning that any attempts to dent relations between Pakistan and Saudi Arabia would not be tolerated at all. On the other hand, PTI leadership maintained that, as Bushra is not a political figure, her statement should not be attributed to the party at large. “Bushra Bibi’s statement has nothing to do with PTI,” said senior PTI leader Shoaib Shaheen. However, Imran Khan seems to be endorsing what his wife had said. While speaking to the media from Rawalpindi’s Adiala Jail, Khan said that his wife had not named Saudi Arabia and that the statement was being twisted to directly target MBS (Muhammad Bin Salman) and Saudi Arabia. Imran Khan’s endorsement of his wife’s controversial statement was also picked up by the government, which slammed both of them for towing anti-state and anti-Pakistan agenda. “Imran Khan did not negate what his wife said and, in fact, he endorsed it. Imran Khan, his party and his so-called non-political wife are on an anti-Pakistan agenda. They are enemies of Pakistan. They can go to any extent to damage our country and its relationship with brotherly countries like Saudi Arabia,” said Azma Bukhari, spokesperson of the Punjab government. “This disgraceful statement from an uneducated and uninformed individual against friendly countries shows she is working on the agenda of hostile elements. The people of Pakistan have now witnessed the true faces of these two deceivers. The so-called ‘Fitna Party’ is no longer acceptable to the nation,” she added while speaking with reporters in Lahore on Saturday.

Election victories for Donald Trump and other candidates whose campaigns demeaned transgender people reinforced a widespread backlash against trans rights. For America’s LGBTQ-rights movement, it adds up to one of the most sustained setbacks in its history. For transgender Americans, it’s personal: There is palpable fear of potential Trump administration steps to further marginalize them. But there is also a spirit of resilience — a determination to persevere in seeking acceptance and understanding. “I just went through an election where I couldn’t watch a sports event on TV without seeing a commercial where trans people were portrayed as monsters,” said Jennifer Finney Boylan, a transgender author who teaches at Barnard College in New York. “This hurts more than any other moment I can remember. We’ve been knocked down before. We’ll be knocked down again. All we can do is fight.” Anti-trans momentum has been growing for several years, with Republican-governed states enacting dozens of laws restricting trans people’s options for medical care, sports participation and public restroom access. Activists fear the movement will grow, with the Trump administration taking power as many Americans question the trans-rights agenda. Overall, 55% of voters — and 85% of Trump backers — said support for transgender rights in government and society has gone too far, according to AP VoteCast, a survey of more than 120,000 people who cast ballots nationwide. “There is an urgent need to show the American people the reality of transgender lives — the ordinary people for whom being trans is not the center of their lives,” said Shannon Minter, a transgender civil rights lawyer with the National Center for Lesbian Rights. “This is a frightening moment for transgender people and their families. There is a very real possibility that the new administration may adopt policies that cause them devastating harm.” Trump won the presidential contest over Vice President Kamala Harris after a campaign that included pervasive TV advertising mocking her support for trans rights. “Kamala is for they/them,” an ad that ran over 15,000 times asserted. “President Trump is for you.” Other Democratic candidates also were targeted with anti-trans ads. On an array of issues, Trump — and other Republicans who now hold majorities in both the House and Senate — have threatened to roll back protections and civil liberties for trans people. Education: Trump has pledged to impose wide-ranging restrictions on transgender students. His administration could swiftly move to exclude them from Title IX protections, which affect school policies on students’ use of preferred pronouns, bathrooms and locker rooms. Health care: At least 26 states have adopted laws restricting or banning gender-affirming medical care for trans minors. In Texas, Attorney General Ken Paxton is filing civil lawsuits against doctors he alleges were prescribing such treatments. Trump says any doctor or hospital providing gender-affirming care should be barred from Medicaid and Medicare. Sports: Trump and other Republicans embraced the anti-trans mantra opposing “boys in girls’ sports.” At least 24 states already have laws on the books barring trans women and girls from participating in certain women’s or girls’ sports competitions. In March, 16 college athletes filed a lawsuit against the NCAA, accusing it of violating their Title IX rights by allowing transgender woman Lia Thomas to compete at the 2022 national championships, where she won the 500-yard freestyle. Military: Trans-rights activists worry that Trump may reimpose a ban on trans people serving openly in the military or — as an alternative — bar any future recruiting of trans people and curtail the availability of gender-affirming medical care for service members and veterans. Trans-rights organizations are calling for coalition-building and renewed efforts to increase public understanding. They celebrated some notable victories. Sarah McBride won Delaware’s lone seat in the House of Representatives to become the first openly trans person elected to Congress. In Montana, transgender state Rep. Zooey Zephyr won reelection and will be able to return to the House floor nearly two years after she was silenced and sanctioned by her Republican colleagues. But nationwide, anger and anxiety were dominant emotions among trans activists. “This election season has been brutal,” the leaders of Advocates for Transgender Equality wrote to their supporters. “Trump targeted trans people since his campaign launch. He targeted our existence. He targeted our rights. He promised he would continue to target trans people if he won — and we know he will keep his promise.” Shelby Chestnut, executive director of the Transgender Law Center, said trans people “have become the pawn for political groups that don’t understand our communities.” “It’s a very precarious time,” Chestnut said. “We will get through this, but we have to step up and support each other. ... How do we see the long game, not just the immediate narrow view? Because it is very daunting right now. Where do we want to be in 15 years?” Public opinion on trans rights issues isn’t uniform. According to AP VoteCast, slightly more than half of voters in the 2024 election strongly or somewhat opposed laws that ban gender-affirming medical treatment, such as puberty blockers and hormone therapy, for minors. Slightly less than half of voters somewhat or strongly favored them. And according to a Gallup poll conducted last year, 69% of Americans say transgender athletes should be allowed to compete only on sports teams that conform with their birth gender. Over the past 25 years, arguably the most daunting previous phase of the LGBTQ-rights movement started in 2004, after Massachusetts became the first state to legalize same-sex marriage. Between 2004 and 2008, voters in 26 states approved ballot measures defining marriage as between one man and one woman — in effect outlawing same-sex marriage. By 2012, however, public opinion was swinging in favor of same-sex marriage. The Supreme Court legalized it nationwide in 2015, and it has had the support of most Americans ever since. Boylan recalled how that long-bitter debate tilted in favor of legalization when supporters of same-sex marriage popularized the phrase “Love is love.” “That opened doors and opened hearts,” Boylan said. “The challenge for trans people is we don’t have a phrase like that. ... The issues are more complex.” Boylan noted that the anti-trans campaign seemed to make headway with issues that are not among the core concerns of most trans people: “The primary thing we’re fighting for is not the right to play with other women on a soccer team. We’re fighting for dignity, for respect, for the right to be left alone.” Maxwell Kuzma, a transgender man working as a film editor and writer in rural Ohio, said he was “worn out” by the relentless targeting of trans people and blamed Trump for perpetuating it. Looking ahead, he said life as a trans person “has forced me to learn a resiliency that I will lean on as I continue to speak out against prejudice and discrimination.” Christine Zuba, a transgender woman from New Jersey, described a recent surge of Zoom meetings enabling trans people to express their concerns and determine next steps. “One of the best recommendations I have heard throughout this discussion is to not isolate yourself; rather surround yourself with your support group — the people you love and who love you,” she said. “Do not despair. There are a lot of people who will work with you and for you.” Get local news delivered to your inbox!

Jayden Daniels and the offense stalling have the Commanders on a three-game losing streak

Taylor Swift sends fans in frenzy with highly anticipated Easter EggNone

jollibee 6 pcs www jilibet.com

Copyright © 2015 jilibet slots All Rights Reserved.